DexCom, Inc. DXCM
82.97 USD -1.79 (-2.11%)
At closeNov 4, 2026, 4:01 AM EST
82.81 -0.16 -0.19%
Pre-market · Nov 4, 4:01 AM ET
82.81 Day range 85.18
54.11 52-week range 92.59
- YTD
- +25.01%
- 1 year
- +37.30%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 98.15 +18.3% upside
Now 82.97
- Target (low)
- 79.00
- Target (mean)
- 98.15
- Target (high)
- 120.00
Ratings (0m) 29 26 buy · 3 hold · 0 sell
- Strong buy4
- Buy22
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 29
- 1 month ago 28
- 2 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.717 | 0.67 – 0.771 | 0.68 | +5.4% | 1.38B | +9.9% | 21 |
| Next quarter | 0.63716 | 0.57 – 0.74 | 0.56 | +13.8% | 1.31B | +10.1% | 17 |
| Current year | 2.70 | 2.45 – 2.78 | 2.09 | +29.2% | 5.23B | +12.1% | 25 |
| Next year | 3.13 | 2.76 – 3.46 | 2.70 | +16.1% | 5.77B | +10.4% | 25 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | Maintained | Buy | Buy |
| Oct 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 30, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2026 | StoneX | Maintained | Buy | Buy |
| Oct 12, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Overweight |
| Oct 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 18, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 18, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Aug 4, 2026 | Argus Research | Maintained | Buy | Buy |
| Aug 3, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 31, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 31, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 31, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 31, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 31, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Jul 31, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 31, 2026 | Benchmark | Maintained | Buy | Buy |
| Jul 31, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 31, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 16, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 23, 2026 | Deutsche Bank | Initiated | Buy | Buy |
| Jun 15, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jun 10, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jun 9, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 5, 2026 | Stifel | Maintained | Buy | Buy |
| May 28, 2026 | Citigroup | Maintained | Buy | Buy |